They manage to stabilize a patient with liver failure using a genetically modified pig liver. The organ was not transplanted ...
He is thankful to the staff at the Royal Infirmary of Edinburgh, from the surgeons to the nurses to the cleaners, for their patience and care. Thankful to his wife Lindsay and their three young ...
Morning Overview on MSN
US team tests 1st nuclear medicine device on cancer patient
A research team at the University of Missouri has treated the first cancer patient with a new nuclear medicine device that targets tumors inside the liver. The early-stage clinical trial focuses on ...
The AISF urges ending judgmental labels, engaging primary care doctors, and building support networks to improve outcomes in alcohol-related and metabolic liver diseases.
MedPage Today on MSN
Statin Adverse Event Labels May Be Overcautious, Analysis Suggests
Study breaks down lack of causal evidence for listed potential adverse effects ...
Prolonged diagnostic latency can follow vague fatigue, back pain, and breathing issues, reinforcing the need for persistent ...
Unmet needs in hepatology continue to evolve globally. While the burden of chronic viral hepatitis continues to decline due to improved treatment and prevention, steatotic liver disease is emerging as ...
Q4 2025 Earnings Call February 10, 2026 6:45 AM ESTCompany ParticipantsAndrew Barnett - Head of Investor RelationsPascal ...
Learn why cytotoxicity test failures are common in medical devices and discover systematic approaches to identify root causes ...
Myers' upcoming $30B patent cliff as the Growth portfolio lost significant potential. Read why BMY stock is downgraded to Hold.
The current recommended 2-step approach using FIB-4 and LSM successfully stratifies patients by risk for advanced fibrosis and future liver-related events.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results